Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The present study was designed to investigate the interaction between 5-methyltetrahydrofolate and tetrahydrobiopterin in modulating endothelial function. Tetrahydrobiopterin is a critical cofactor for nitric oxide synthase and maintains this enzyme as a nitric oxide- versus superoxide-producing enzyme. The structure of 5-methyltetrahydrofolate is similar to tetrahydrobiopterin and both agents have been shown to improve endothelium-dependent vasodilatation. We hypothesized that 5-methyltetrahydrofolate interacts with nitric oxide synthase in a fashion analogous, yet independent, of tetrahydrobiopterin to improve endothelial function. We demonstrate that 5-methyltetrahydrofolate binds the active site of nitric oxide synthase and mimics the orientation of tetrahydrobiopterin. Furthermore, 5-methyltetrahydrofolate attenuates superoxide production (induced by inhibition of tetrahydrobiopterin synthesis) and improves endothelial function in aortae isolated from tetrahydrobiopterin-deficient rats. We suggest that 5-methyltetrahydrofolate directly interacts with nitric oxide synthase to promote nitric oxide (vs. superoxide) production and improve endothelial function. 5-Methyltetrahydrofolate may represent an important strategy for intervention aimed at improving tetrahydrobiopterin bioavailability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly
Beckman, J. S., & Koppenol, W. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.5.c1424 · Cited by 5,513
Heitzer, T., Krohn, K., Albers, S., & Meinertz, T. (2000) · Diabetologia · doi:10.1007/s001250051551 · Cited by 427 · cited 1×
“Recent studies (11, 20) have indicated that BH4 may be deficient in states of insulin resistance and diabetes whereas eNOS expression is increased by insulin.”
BackgroundShinozaki, K., Kashiwagi, A., Nishio, Y., Okamura, T., Yoshida, Y., Masada, M., Toda, N., & Kikkawa, R. (1999) · Diabetes · doi:10.2337/diabetes.48.12.2437 · Cited by 329
Folic Acid Reverts Dysfunction of Endothelial Nitric Oxide Synthase
Stroes, E. S. G., van Faassen, E. E., Yo, M., Martasek, P., Boer, P., Govers, R., & Rabelink, T. J. (2000) · Circulation Research · doi:10.1161/01.res.86.11.1129 · Cited by 285 · cited 4×
“In addition, extracellular antioxidants such as superoxide dismutase are more relevant in vivo for scavenging superoxide compared with 5-MTHF (23).”
BackgroundInfluentialTetrahydrobiopterin Improves Endothelial Function in Patients with Coronary Artery Disease
Maier, W., Cosentino, F., Lütolf, R. B., Fleisch, M., Seiler, C., Hess, O. M., Meier, B., & Lüscher, T. F. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200002000-00001 · Cited by 217 · cited 1×
“Recent reports (10, 17, 22, 24, 25) indicate that supplementation with BH4 improves endothelium-dependent vasodilatation in experimental diabetes, models of ischemia and reperfusion injury, hypercholesterolemia, and cigarette smoking.”
Background
Cited by
Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics
Tsai, E. J., & Kass, D. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.009 · Cited by 420
Antoniades, C., Shirodaria, C., Warrick, N., Cai, S., de Bono, J., Lee, J., Leeson, P., Neubauer, S., Ratnatunga, C., Pillai, R., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.612325 · Cited by 365
Folate, homocysteine, endothelial function and cardiovascular disease
Moat, S. J., Lang, D., McDowell, I. F. W., Clarke, Z. L., Madhavan, A. K., Lewis, M. J., & Goodfellow, J. (2004) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2003.08.010 · Cited by 261
Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart
Umar, S., & van der Laarse, A. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0219-x · Cited by 182
“Tetrahydrobiopterin (BH4) plays a key role in maintaining normal NOS3 coupling, and folic acid, as well as 5-methyltetrahydrofolate can increase BH4 levels by facilitating enzymatic reduction of its oxidized forms [62] and are associated with improved endothelial function [63].”
BackgroundRegulation of Tetrahydrobiopterin Synthesis and Bioavailability in Endothelial Cells
Shi, W., Meininger, C. J., Haynes, T. E., Hatakeyama, K., & Wu, G. (2004) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:41:3:415 · Cited by 137
“In addition, 5methyltetrahydrofolate directly attenuates superoxide production in the vasculature (114).”
BackgroundTetrahydrobioterin (BH4) pathway: from metabolism to neuropsychiatry
Fanet, H., Capuron, L., Castanon, N., Calon, F., & Vancassel, S. (2021) · Current Neuropharmacology · doi:10.2174/1570159x18666200729103529 · Cited by 134
Synergy of genes and nutrients: the case of homocysteine
Lucock, M. D. (2006) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/01.mco.0000247468.18790.1e · Cited by 24
McCarty, M. (2015) · Healthcare · doi:10.3390/healthcare3020233 · Cited by 23
Metadata
- Authors
- Hyndman, M. E., Verma, S., Rosenfeld, R. J., Anderson, T. J., & Parsons, H. G.
- Venue
- American Journal of Physiology-Heart and Circulatory Physiology
- Publisher
- American Physiological Society
- Published
- 2002-06-01
- Volume
- 282
- Issue
- 6
- Pages
- H2167-H2172
- ISSN
- 0363-6135 (ISSN-L)
- 1522-1539
- OpenAlex
- W2143707614
- Cited by
- 122
- References
- 5
- FWCI
- 3.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.